West pharmaceutical services, inc. (WST)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Net income

260,600

241,700

229,800

228,700

218,700

206,900

154,900

150,700

133,400

150,700

189,800

176,400

182,400

143,600

137,900

101,800

84,800

95,600

93,600

123,100

132,900

127,100

119,300

115,100

107,700

112,300

109,800

97,800

83,200

80,700

78,400

80,600

85,100

75,500

62,700

63,400

65,100

65,300

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation

100,000

100,000

100,200

101,300

100,900

101,700

100,500

99,500

97,400

94,300

92,100

89,800

89,100

88,100

88,400

87,700

86,700

86,100

84,500

84,300

85,200

84,800

85,000

84,500

82,200

81,000

79,100

76,700

74,700

72,800

70,800

69,800

70,300

71,100

72,300

72,100

70,500

68,800

0

0

0

Amortization

3,900

3,400

3,200

3,000

2,600

2,700

2,500

2,300

2,400

2,400

2,500

2,700

2,600

2,600

2,800

3,000

3,500

3,800

4,100

5,000

5,000

5,200

5,100

4,400

4,300

4,200

4,200

4,000

4,100

4,100

4,300

4,500

4,500

4,600

4,500

4,500

4,500

4,400

0

0

0

Loss on debt extinguishment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-200

-200

-200

-11,800

-11,600

0

0

0

-

-

-

-

-

-

-

-

Stock-based compensation

23,600

24,400

19,200

19,100

17,900

15,100

17,200

16,500

16,000

16,100

19,000

19,000

18,400

19,500

19,300

18,300

28,900

29,600

30,500

30,500

19,600

18,600

18,100

19,700

20,100

21,200

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Pension settlement charge

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash restructuring charges

2,000

2,300

3,000

2,200

2,400

2,200

1,500

1,100

800

700

1,600

2,500

2,500

17,500

15,900

15,000

15,000

0

0

0

0

-

-

-

-

-

-

-

-

6,200

0

0

0

-

-

-

-

-

-

-

-

Contingent consideration payments in excess of acquisition-date liability

400

500

400

400

600

600

500

500

200

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets/liabilities, net of acquisitions:
Other non-cash items, net

-6,100

-9,600

-31,700

-30,400

-30,200

-28,300

11,800

10,800

10,500

11,000

17,400

24,800

20,100

17,900

-51,500

-51,900

-60,200

-100

11,800

-2,200

10,800

-7,100

9,000

15,700

-9,900

-15,300

-31,900

-43,400

-18,200

-19,700

4,600

11,400

12,400

7,800

0

0

0

-

-

-

0

Changes in assets and liabilities

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

Net cash provided by operating activities

376,700

367,200

334,000

314,300

291,200

288,600

296,900

284,300

287,600

263,300

253,600

246,200

237,100

219,400

215,600

216,000

217,300

212,400

190,400

185,500

172,200

182,900

205,700

195,100

210,400

220,500

221,500

219,800

192,500

187,400

159,400

147,500

135,000

130,700

136,100

144,400

136,300

138,300

0

0

0

Cash flows from investing activities:
Capital expenditures

129,700

126,400

118,800

113,600

105,500

104,700

104,200

112,000

121,300

130,800

148,800

163,200

168,700

170,200

167,500

148,500

140,200

131,600

113,900

112,800

110,600

111,900

123,600

124,300

121,900

151,900

146,000

145,700

160,600

131,300

131,800

127,000

108,400

95,400

83,300

76,300

72,800

71,100

0

0

0

Acquisition of patents and other long-term assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

1,400

0

0

0

-

-

0

0

Sales and maturities of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16,800

17,600

13,700

14,500

19,100

31,800

32,000

50,400

45,600

0

0

0

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,300

10,200

14,700

18,000

14,200

17,200

14,000

32,000

31,200

0

0

0

-

-

-

-

-

-

-

-

Acquisition of businesses, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,700

0

0

0

Sales of investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,900

20,700

19,200

8,900

0

0

0

Other, net

-2,500

-2,400

-1,700

-1,600

-4,700

-3,900

-2,600

-2,900

300

-3,200

-3,900

-4,400

-5,200

-2,800

-4,400

-3,800

-4,200

-3,600

-2,700

-1,900

-600

-1,100

-3,500

-4,200

-1,500

-1,000

1,600

1,700

-1,100

-1,600

-1,600

-1,600

-1,900

-1,900

-1,500

-2,300

-2,100

-1,800

0

0

0

Net cash used in investing activities

-231,200

-228,000

-136,000

-130,900

-100,800

-100,800

-101,600

-109,100

-127,600

-133,600

-150,900

-164,800

-171,900

-175,800

-173,000

-154,600

-137,500

-129,500

-111,900

-103,100

-99,000

-104,000

-116,600

-125,000

-127,800

-149,900

-133,700

-130,100

-141,800

-116,000

-129,600

-136,100

-123,300

-120,500

-102,800

-89,600

-83,400

-74,000

0

0

0

Cash flows from financing activities:
Borrowings under revolving credit agreements

80,500

108,500

28,000

28,000

28,000

0

0

0

0

-

-

-

-

-

-

-

65,100

71,400

98,400

124,100

144,400

263,400

265,300

297,300

299,000

292,700

343,300

548,000

658,000

568,300

651,700

386,000

216,700

193,400

0

0

0

-

-

-

0

Repayments under revolving credit agreements

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

70,400

71,400

98,400

134,100

191,100

283,400

312,100

332,300

328,600

311,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,200

43,400

211,400

211,400

168,100

0

0

0

-

-

-

-

-

-

-

-

Repayments of Long-term Debt

0

-

-

-

0

-

-

-

-

34,900

2,400

2,400

2,400

69,800

69,900

94,800

94,800

27,400

27,300

2,400

2,300

2,300

2,300

2,300

2,200

30,500

29,900

79,500

244,700

215,900

0

0

0

-

-

-

-

-

-

-

-

Issuance of long-term debt

400

1,200

900

900

800

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in other debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,800

-1,100

-1,100

-1,100

0

0

0

Dividend payments

45,800

45,100

44,400

43,600

42,800

42,100

41,400

40,700

40,000

39,100

38,300

37,400

36,600

35,800

34,900

34,100

33,200

32,400

31,600

30,800

29,900

29,100

28,200

27,700

27,300

26,700

26,300

25,800

25,300

24,900

24,400

24,000

23,900

23,200

22,800

22,400

21,800

21,700

0

0

0

Contingent consideration payments up to amount of acquisition-date liability

-

-

-

-

-

-

-

-

-

-700

-700

-500

-400

-300

-100

0

0

-100

-200

-300

-500

-300

-300

-200

0

-100

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from stock-based compensation awards

28,100

25,100

27,200

37,100

30,400

27,400

25,400

12,700

17,900

35,700

40,100

35,700

31,400

25,900

24,800

24,200

18,700

12,700

13,500

17,300

18,500

14,300

17,100

16,200

18,600

21,700

18,800

16,500

13,400

8,700

3,700

2,900

4,000

3,900

6,000

5,200

2,500

3,700

0

0

0

Employee stock purchase plan contributions

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Excess tax benefit from employee stock plans

-

-

-

-

-

-

-

-

-

-

-

-

-

18,200

18,800

18,700

17,200

9,100

6,600

7,700

8,100

7,900

9,400

10,900

9,900

8,300

7,000

3,900

5,700

4,900

2,600

2,500

2,600

3,500

3,300

3,200

1,300

2,100

0

0

0

Shares purchased under share repurchase programs

115,500

83,100

83,100

83,100

106,000

70,800

118,300

118,300

95,400

74,400

52,300

61,900

70,000

52,200

26,800

17,200

9,100

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

3,600

3,500

2,200

2,100

0

0

0

Shares repurchased for employee tax withholdings

-

-

-

-

-

-

-

-

-

-

3,800

3,800

3,800

3,700

3,700

3,700

3,600

5,600

5,600

5,600

5,700

4,100

4,100

4,100

6,400

5,200

7,700

7,700

7,000

4,700

0

0

0

-

-

-

-

-

-

-

-

Net cash used in financing activities

-66,600

-36,800

-96,000

-85,500

-114,300

-80,700

-159,000

-172,100

-144,100

-109,000

-48,900

-60,900

-70,600

-113,900

-89,100

-104,500

-107,800

-41,500

-41,700

-21,300

-55,800

-30,800

-52,500

-39,400

-34,400

-5,100

-11,100

-6,500

27,900

-3,400

-2,000

-3,600

-600

-24,700

-11,200

-21,500

-28,000

-34,000

0

0

0

Effect of exchange rates on cash

-9,100

-700

-3,300

3,300

-10,400

-5,600

-8,300

-4,200

14,500

12,200

9,600

3,400

-3,300

-1,300

-4,400

-6,200

-1,000

-22,100

-26,800

-35,800

-40,300

-22,800

-11,500

5,400

6,800

2,600

1,800

400

-3,800

2,100

-3,800

-11,200

-5,500

-3,900

0

9,600

3,800

-3,200

0

0

0

Net decrease in cash and cash equivalents

69,800

101,700

98,700

101,200

65,700

101,500

28,000

-1,100

30,400

32,900

63,400

23,900

-8,700

-71,600

-50,900

-49,300

-29,000

19,300

10,000

25,300

-22,900

25,300

25,100

36,100

55,000

68,100

78,500

83,600

74,800

70,100

24,000

-3,400

5,600

-18,400

22,100

42,900

28,700

27,100

0

0

0